Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.


BACKGROUND Recent epidemiologic evidence suggests that higher circulating vitamin D does not protect against prostate cancer and, in fact, may increase the risk of developing this malignancy. However, few studies have examined the most clinically relevant outcome, prostate cancer mortality. METHODS We examined prediagnostic serum 25-hydroxy-vitamin D (25… (More)
DOI: 10.1158/1055-9965.EPI-15-0991

4 Figures and Tables



Citations per Year

Citation Velocity: 14

Averaging 14 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.
  • Blog articles referencing this paper

  • Presentations referencing similar topics